Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 4
1953 4
1954 3
1955 1
1956 2
1959 1
1962 1
1964 1
1966 1
1968 1
1969 1
1972 1
1973 5
1974 4
1975 3
1976 7
1977 4
1978 4
1979 7
1980 8
1981 12
1982 2
1983 9
1984 7
1985 11
1986 9
1987 3
1988 16
1989 10
1990 7
1991 10
1992 14
1993 12
1994 11
1995 13
1996 18
1997 16
1998 22
1999 14
2000 17
2001 9
2002 14
2003 15
2004 15
2005 12
2006 17
2007 17
2008 22
2009 18
2010 26
2011 28
2012 26
2013 26
2014 25
2015 17
2016 22
2017 25
2018 21
2019 23
2020 24
2021 25
2022 27
2023 25
2024 23
2025 26

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

751 results

Results by year

Filters applied: . Clear all
Page 1
Asthma Exacerbations: Pathogenesis, Prevention, and Treatment.
Castillo JR, Peters SP, Busse WW. Castillo JR, et al. Among authors: busse ww. J Allergy Clin Immunol Pract. 2017 Jul-Aug;5(4):918-927. doi: 10.1016/j.jaip.2017.05.001. J Allergy Clin Immunol Pract. 2017. PMID: 28689842 Free PMC article. Review.
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma.
Castro M, Corren J, Pavord ID, Maspero J, Wenzel S, Rabe KF, Busse WW, Ford L, Sher L, FitzGerald JM, Katelaris C, Tohda Y, Zhang B, Staudinger H, Pirozzi G, Amin N, Ruddy M, Akinlade B, Khan A, Chao J, Martincova R, Graham NMH, Hamilton JD, Swanson BN, Stahl N, Yancopoulos GD, Teper A. Castro M, et al. Among authors: busse ww. N Engl J Med. 2018 Jun 28;378(26):2486-2496. doi: 10.1056/NEJMoa1804092. Epub 2018 May 21. N Engl J Med. 2018. PMID: 29782217 Free article. Clinical Trial.
An expert consensus framework for asthma remission as a treatment goal.
Menzies-Gow A, Bafadhel M, Busse WW, Casale TB, Kocks JWH, Pavord ID, Szefler SJ, Woodruff PG, de Giorgio-Miller A, Trudo F, Fageras M, Ambrose CS. Menzies-Gow A, et al. Among authors: busse ww. J Allergy Clin Immunol. 2020 Mar;145(3):757-765. doi: 10.1016/j.jaci.2019.12.006. Epub 2019 Dec 19. J Allergy Clin Immunol. 2020. PMID: 31866436 Free article. Review.
Type 2 immunity in the skin and lungs.
Akdis CA, Arkwright PD, Brüggen MC, Busse W, Gadina M, Guttman-Yassky E, Kabashima K, Mitamura Y, Vian L, Wu J, Palomares O. Akdis CA, et al. Among authors: busse w. Allergy. 2020 Jul;75(7):1582-1605. doi: 10.1111/all.14318. Epub 2020 May 10. Allergy. 2020. PMID: 32319104 Review.
Reply.
Jackson DJ, Busse WW, Togias A, Gern JE, Altman MC. Jackson DJ, et al. Among authors: busse ww. J Allergy Clin Immunol. 2020 Nov;146(5):1214-1215. doi: 10.1016/j.jaci.2020.07.028. Epub 2020 Aug 14. J Allergy Clin Immunol. 2020. PMID: 32828589 Free PMC article. No abstract available.
Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial.
FitzGerald JM, Bleecker ER, Nair P, Korn S, Ohta K, Lommatzsch M, Ferguson GT, Busse WW, Barker P, Sproule S, Gilmartin G, Werkström V, Aurivillius M, Goldman M; CALIMA study investigators. FitzGerald JM, et al. Among authors: busse ww. Lancet. 2016 Oct 29;388(10056):2128-2141. doi: 10.1016/S0140-6736(16)31322-8. Epub 2016 Sep 5. Lancet. 2016. PMID: 27609406 Clinical Trial.
Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe Asthma.
Busse WW, Maspero JF, Rabe KF, Papi A, Wenzel SE, Ford LB, Pavord ID, Zhang B, Staudinger H, Pirozzi G, Amin N, Akinlade B, Eckert L, Chao J, Graham NMH, Teper A. Busse WW, et al. Adv Ther. 2018 May;35(5):737-748. doi: 10.1007/s12325-018-0702-4. Epub 2018 May 3. Adv Ther. 2018. PMID: 29725983 Free PMC article. Clinical Trial.
Baseline FeNO Independently Predicts the Dupilumab Response in Patients With Moderate-to-Severe Asthma.
Pavord ID, Deniz Y, Corren J, Casale TB, FitzGerald JM, Izuhara K, Daizadeh N, Ortiz B, Johnson RR, Harel S, Djandji M, Goga L, Crikelair N, Rowe PJ, Busse WW. Pavord ID, et al. Among authors: busse ww. J Allergy Clin Immunol Pract. 2023 Apr;11(4):1213-1220.e2. doi: 10.1016/j.jaip.2022.11.043. Epub 2022 Dec 16. J Allergy Clin Immunol Pract. 2023. PMID: 36535524 Free article. Clinical Trial.
Asthma.
Busse WW, Lemanske RF Jr. Busse WW, et al. N Engl J Med. 2001 Feb 1;344(5):350-62. doi: 10.1056/NEJM200102013440507. N Engl J Med. 2001. PMID: 11172168 Review. No abstract available.
Asthma.
Lemanske RF Jr, Busse WW. Lemanske RF Jr, et al. Among authors: busse ww. JAMA. 1997 Dec 10;278(22):1855-73. JAMA. 1997. PMID: 9396647 Review.
751 results